SLC2A9 and hyperuricemia: It downregulates renal GLUT9 to enhance uric acid excretion; inhibits inflammatory pathways and cytokine production; boosts antioxidant enzyme activity; and suppresses renal cell apoptosis and endoplasmic reticulum stress, thereby improving hyperuricemia and associated renal injury (Liu H. et al., 2025).